Iterum Therapeutics (ITRM)
(Delayed Data from NSDQ)
$1.01 USD
+0.01 (0.90%)
Updated Oct 4, 2024 03:59 PM ET
After-Market: $1.00 -0.01 (-0.50%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Earnings News For ITRM
-
Iterum Therapeutics Reports Second Quarter 2024 Financial Results
-
Iterum Therapeutics Reports First Quarter 2024 Financial Results
-
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
-
Iterum Therapeutics Reports Third Quarter 2023 Financial Results
-
Iterum Therapeutics Reports Second Quarter 2023 Financial Results
-
Iterum Therapeutics Reports First Quarter 2023 Financial Results
-
Iterum Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
-
Iterum Therapeutics Reports Third Quarter 2022 Financial Results
-
Iterum Therapeutics PLC (ITRM) Reports Q3 Loss, Lags Revenue Estimates
-
Earnings Preview: Iterum Therapeutics PLC (ITRM) Q3 Earnings Expected to Decline
-
Iterum Therapeutics PLC (ITRM) Reports Q2 Loss, Misses Revenue Estimates
-
Iterum Therapeutics PLC (ITRM) May Report Negative Earnings: Know the Trend Ahead of Q2 Release